COVID-19 vaccines, if developed in India, need antibody response in at least 50% cases for approval
By Administrator_India Capital Sands According to the draft guidelines for the development of COVID-19 vaccines, a vaccine developed in India should prove that at least 50 percent of those administered with the vaccine are protected from the virus to get an approval. For vaccines that are being developed outside India, the authorisation will be provided […]